Mutation of the parkin gene, compositions, methods and uses
CA 2872581 C · Owner: Institut National De La Sante Et De La Recherche Medicale · Inventors: Bouley, Sandrine; Denefle, Patrice; Brice, Alexis
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention concerns nucleic acids coding for forms of the human parkin gene mutated, truncated or comprising exon multiplications and the corresponding proteins and antibodies. It also concerns methods and kits for the identification of mutations of the parkin gene as well as for the study of compounds with a therapeutic aim.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 18, 1999 and granted April 10, 2018. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 18, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 18, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.